Testing the safety of a new oral drug in healthy men
This trial tests a new oral medication, called FB-101, in healthy adult men to see how safe it is and how the body processes it. Participation involves multiple visits and taking the drug in different doses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy man between 19 and 55 years old.
- Have a body mass index (BMI) between 18.5 and 30.0.
- Be a non-smoker and have not used nicotine products for at least 3 months.
- Be in good overall health with no major medical or mental health conditions.
- If not vasectomized, agree to use condoms with spermicide during the study and for 90 days after the last dose.
- Be able to swallow multiple capsules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial is testing a new drug called NSHO-101 in healthy people to see how the body processes it and if it is safe. It helps researchers learn about the drug before testing it in patients with a condition.
This trial tests a new medicine called BCD-261 in healthy men to see if it is safe and how the body processes it. Participants will receive increasing doses and be monitored for about 4 months.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
This trial studies a new drug called FB418 to see if it's safe and how the body handles it. It first tests single doses in younger healthy men, then multiple doses, and also includes an optional group for healthy older adults.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.